HIVACAR Phase I/IIa clinical trial protocol
(si apre in una nuova finestra)
HIVACAR Phase I/IIa clinical trial protocol: A document containing the description of the clinical trial, the research brochure and all other documents requested by the MEC’s for all sites of clinical intervention.
Final report on dissemination activities
(si apre in una nuova finestra)
Final report on dissemination activities A detailed list of all dissemination activities carried out during the project with assessment of their impact and degree of compliance with the plan
Data Management Plan
(si apre in una nuova finestra)
The Data Management Plan will be prepared at month 12 and an updated version will be delivered at month 30.
Final Briefing Document sent to EMA to request Scientific Advice containing information on the quality, nonclinical and clinical development program
(si apre in una nuova finestra)
Final exploitation and sustainability plan
(si apre in una nuova finestra)
Final exploitation and sustainability plan This report will analyse the exploitation and sustainability models to exploit and promote the use of the HIVACAR results beyond the project life
Intermediate report on dissemination activities
(si apre in una nuova finestra)
Intermediate report on dissemination activities: A detailed list of dissemination activities carried out halfway through the project, with assessment of their impact, the degree of compliance with the plan, and a description of foreseen dissemination activities until the end of the project.
Targeted communication tools
(si apre in una nuova finestra)
Targeted communication tools: This deliverable includes tools such as: 1) The review and adaption of the clinical trial synopsis and informative materials to be shared with the participants and the community; 2) Creation of leaflets and other informative materials informing on the project objectives and expected outcomes; 3) The creation of a communication tool (such as an online forum) where the patients enrolled in the clinical trial can raise questions regarding the trial development, share their concerns and expectations regarding their participation. The tool will also allow monitoring and prevent possible dropouts and to manage expectations regarding the outcomes of the project.
Final assessment of the project
(si apre in una nuova finestra)
Final assessment of the project At the end of the project a final assessment of the degree of fulfilment of the objectives of the project including an assessment of the use cases will be carried out and reported in this deliverable For both D13 and D14 the responsible of performing the assessment of the project will be the project coordinator Dr Felipe Garca with the input and advice from both the Steering Committee and the Scientific Advisory Board
